secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001638833-23-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q4 revenue up 15.9% to $707.1M; sets 2023 EBITDA guidance >$425M
--------------------------------------------------------------------------------

- Revenue $707.1M in Q4 (+15.9% YoY); full-year revenue $2.5B (+14.1%).
- Net loss attributable to common $23.4M in Q4; full-year net loss $54.6M.
- Adjusted EBITDA $120.8M in Q4 (+5.6% YoY); full-year $380.2M (+12.0%).
- Days adjusted same-facility revenue +10.7% in Q4; +7.7% for full year.
- 2023 guidance: revenue >$2.75B, Adjusted EBITDA >$425M; liquidity >$830M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/sgry-20230301.htm
  HTML page:      https://secwatch.observer/filing/0001638833-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer